Wuhan buy Cannabis

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Wuhan buy Cannabis

Wuhan General Group China , Inc. This will secure the proper supply chain to provide high quality cannabis products from all around the world that can be purchased at a retail store nearby as well as online. This alliance will also position Wuhan as a leader in curating the knowledge and clinical research to educate our consumers on the products provided and assist them in their purchases. While Canada is not alone in doing so, this legislative barrier can only be penetrated by forming an alliance between different parties in the supply chain to maintain a profitable business in the long-term. In essence, Wuhan is pursuing the same business model that airlines utilise to provide their travelers a wider reach globally without undertaking enormous operational costs. In a world and time of decentralized partnership, the strategic move is to create profitable and sustainable relationships that will provide us, and in consequence consumers with access to valuable clinical research and quality medicinal cannabis products formulated to address health problems such as cardiovascular diseases, diabetes, melanoma, depression and so much more. Building these partnerships and establishing a worldwide alliance is the smartest path to securing a lasting profitable position in a hot market that is new at the moment. The most strategic move for us to expand globally and sustain our long-term growth would be to build partnerships through this alliance in order to break barriers to international entry. For this reason, we are currently in negotiation with multiple parties involved in the cannabis space around the globe with different licences and products that we aim to import in to Canada's market first, and extend it to other adjacent country and so forth. This is a very exciting time as we are on the verge of partnering with cultivators, processing facilities, and clinical research centers which will enable us to offer a variety of CBD products in that aren't yet available in retail or online stores. Our online store is designed and developed, ready to launch in early along with a rewards program that will drive customer loyalty and encourage sales through iOS and Android apps,' says Ramy Kamaneh, CEO of Wuhan. Wuhan General Group is an alternative medicinal and botanicals company focused on the application of emerging technologies as well as the clinical research and health application of cannabidiol CBD -based medicine to the human and pet care industry for cancer, cardiovascular, mental disorders, chronic pain, and others in Canada, the United States, Europe, and Australia. We're on track to achieve a positive cash flow in the first quarter of For further information, contact: Public Relations E-mail: info wuhn. Safe Harbour Statement - In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of and the Securities Exchange Act of , as amended by the Private Securities Litigation Reform Act of Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements. Accessibility: Skip TopNav.

Yahoo Finance

Wuhan buy Cannabis

OTC PINK: WUHN 'Wuhan' or the 'Company' , a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research, is pleased to announce the signing of a distribution agreement with Medigrow Africa 'Medigrow' , an African based medical cannabis company with a formal network of legal African cannabis growers producing international medical-grade cannabis products for global distribution. Under the distribution agreement, Wuhan will receive commercial licenses and rights to Medigrow's portfolio of medical-grade cannabis and hemp products. In the terms, Wuhan is granted the rights and will be responsible for marketing, distribution, and sales of certain Medigrow proprietary natural hemp and cannabis-based products. The Medigrow portfolio of international-grade medical cannabis products is a very tactical addition to our range of products and it really strengthens our commitment to medical cannabis,' said Jeff Robinson, CEO of Wuhan. This partnership will reinforce our brands Dr. Anna , CMO of Wuhan. We share a common vision and execution strategies that will enable us to build a very profitable global powerhouse. Medigrow Africa is a formal network of legal African cannabis growers producing international-grade medical cannabis products for global distribution. Medigrow Africa is the the largest collective of African cannabis businesses and it dominates the African medicinal cannabis industry. Medigrow benefits from lower labor, land, and regulatory costs. Also, Medigrow is in the lower quartile of production costs and the upper quartile of profitability globally. Africa is no different, which is evident in the number of countries that have legalized medicinal cannabis production recently. In the longer term, we are convinced that the African Cannabis Industry can help bring steady income to many people that lack work today, assist in building up infrastructure, and blur social stigmas while providing world-class medicinal cannabis to the globe. Furthermore, we are investigating a range of initiatives to preserve ecosystem integrity, protect biodiversity and enhance agricultural sustainability. Wuhan General Group, Inc. In addition, its new wholly-owned division, M2Bio is researching and developing indications for psilocybin new therapies that will help patients who suffer from addiction, mental illness, Alzheimer's and Parkinson's. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research and emerging technologies. Website: www. E-mail: info wuhn. Safe Harbour Statement - In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of and the Securities Exchange Act of , as amended by the Private Securities Litigation Reform Act of Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements. View source version on accesswire. Selected edition. Sign in. My Portfolio News Latest News. Stocks: Most Actives. Credit Cards. Latest News. Wed, Jun 10, , PM. Story Continues. Privacy Policy.

Wuhan buy Cannabis